California med spa & injectable regulations
What’s changing for med spas and injectors in California — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in California. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Opening a med spa in California? Start with who may own one, the medical director rules, and who may inject in California →
Latest California changes
No California-specific changes have crossed our radar yet — we’re actively monitoring the California legislature and licensing boards. The federal changes below apply to every California practice today.
Federal changes that apply in California
FDA and Federal Register actions are nationwide — they govern California practices too.
- CAUTIONFEDERALFederal RegisterJul 30, 2026
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
New FDA fees for outsourcing facilities will impact med spas using compounds.
- CRITICALFEDERALFDA Warning LetterJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
FDA warns Spa De Soleil over drug compounding practices.
- MONITORFEDERALFederal RegisterJun 26, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
FDA extends comment period on GLP-1 compounding decisions.
- CRITICALFEDERALFDA Warning LetterJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA Warning Letter issued to ketaminelab.org for drugs.
- CRITICALFEDERALFTC EnforcementJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
- CAUTIONFEDERALFDA Drug ShortagesJun 11, 2026
FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide is still on the FDA shortage list for compounding.
What we monitor in California
- California legislature — bills on injectables, GLP-1s & scope of practice
- California Board of Nursing — injector scope & delegation
- California Medical Board — physician supervision & ownership rules
- California Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
California med-spa compliance rules
15 rules across 7topics — physician delegation, the good-faith exam, ownership & corporate practice of medicine, RN/NP scope, med-spa registration, advertising, and enforcement — each linked to its primary source. Reference and monitoring, not legal advice.
Physician supervision & delegation
In California, using prescriptive drugs (Botox, fillers) and prescriptive/energy devices (lasers, IPL) for cosmetic reasons IS the practice of medicine.
A physician may delegate injectable and laser procedures only to appropriately licensed personnel — registered nurses, nurse practitioners, or physician assistants — under genuine supervision. Unlicensed staff (including medical assistants) and improperly licensed staff (estheticians, cosmetologists, LVNs) may not perform them, regardless of training. A “paper” medical-director arrangement is aiding and abetting the unlicensed practice of medicine.
Cal. Bus. & Prof. Code §2052; Medical Board of California — Medical Spas guidance
For an elective cosmetic laser or IPL procedure performed by a licensed provider, a trained physician must be “immediately available” — reachable without delay and able to direct throughout the procedure.
Good-faith examination
California requires an appropriate good-faith exam before prescriptive drugs or devices are used — and it may not be delegated to an RN.
Prescribing, dispensing, or furnishing a dangerous drug (such as Botox or fillers) without an appropriate prior examination and a medical indication is unprofessional conduct.
Per the Medical Board, the required prior examination may NOT be delegated to a registered nurse — a physician (or an NP or PA under standardized procedures) must perform the good-faith exam and issue a patient-specific order before an RN performs the injection or laser treatment.
Ownership & corporate practice of medicine
California strongly bars the corporate practice of medicine. This is the opposite of a permissive-ownership state.
Corporations and other artificial legal entities have no professional rights, privileges, or powers — laypersons and lay entities may not own any part of a medical practice or control clinical decisions.
The compliant structure is a professional medical corporation under the Moscone-Knox Act: a majority of shares must be held by California-licensed physicians, only enumerated licensed health professionals may hold shares (up to 49% in aggregate), and no lay person may hold any stock.
A lay-owned management services organization (MSO) may provide administrative/back-office services by contract, but may not control medical records, clinical hiring/firing, coding/billing, or the selection of medical equipment or drugs — doing so is illegal corporate practice of medicine.
Effective Jan 1, 2026, SB 351 bars a private-equity group or hedge fund from controlling or interfering with a practice’s professional judgment (diagnostics, referrals, treatment, coding/billing, clinical staffing, equipment), voids certain non-compete and non-disparagement clauses, and empowers the Attorney General to enforce.
RN / NP scope for injectables
A registered nurse may inject Botox/fillers or operate a laser only after a physician, NP, or PA has performed the good-faith exam and issued a patient-specific order, and only within standardized procedures in an organized health care system — not as an independent salon practice.
Under standardized procedures, an NP (unlike an RN) may be delegated the prior good-faith exam and the ordering of the drug or device. AB 890’s autonomous-NP categories do not carve out or specially authorize aesthetic practice, and an autonomous NP remains bound by the good-faith-exam and CPOM rules.
Med-spa registration & licensing
California has no dedicated med-spa license or registration category. A medical spa is legally a medical practice under the Medical Practice Act; per the Medical Board, “there are no separate laws governing these procedures,” and physicians are held to the same standard as in their routine practice.
Medical Board of California — Medical Spas guidance; Bus. & Prof. Code §2052
Advertising rules
A licensed practitioner may not disseminate any false, fraudulent, misleading, or deceptive communication to induce patronage — expressly reaching undisclosed altered images, unsubstantiated superiority claims, and misleading “as low as” price teasers. A violation is a misdemeanor and separate grounds for discipline.
Untrue or misleading advertising is separately unlawful as a misdemeanor, and deceptive business practices are actionable under the Unfair Competition Law.
Disciplinary landscape
Unlicensed practice of medicine is a crime — punishable by a fine up to $10,000 and up to a year in county jail (or imprisonment under Penal Code §1170(h)) — and the same penalties reach aiding, abetting, or conspiring with an unlicensed practitioner. This is the statute that catches lay-owned spas practicing medicine and physicians who lend their license.
The Medical Board separately disciplines its licensees (revocation, suspension, probation, fines) for unprofessional conduct — including acting without a good-faith exam, improper delegation, illegal business/CPOM arrangements, fee-splitting, and false advertising.
Current as of Jul 26, 2026. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts.
California med spa compliance — FAQ
- Where do California med spa and injectable regulations come from?
- California med spas and injectors are governed by a mix of state and federal authorities — the California legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for California and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in California?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in California. We track those federal changes alongside any California-specific rules so you see the full picture for your practice.
- How do I keep up with California regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across California, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Get California changes as they publish
We scan the California legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All states · Regulatory monitoring, not legal advice.